APT:ASX remains under Algo Engine buy conditions.
The company released its 3Q21 update to the market, with sales of $5.2bn. This reflects a doubling in revenue on the same time last year.
APT have informed the market, they will be considering the possibility of a US listing.
WPL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Coles Group is under Algo Engine buy conditions.
Investors should watch the short-term momentum indicators for a turn higher within the highlighted range.
CSL:ASX is under Algo Engine buy conditions.
1H21 NPAT of US$1.8bn. FY21 guidance retained at US$2.2bn, which implies a weaker 2H21. We expect to see earnings upgraded prior to the completion of the 2H.
CSL trades on a forward yield of 1%.
Amcor is under Algo Engine buy conditions. We expect buying support to hold above $15.00.
Investors may consider selling out-of-the-money call options to enhance the income.
TCL:ASX is under Algo Engine buy conditions and has now rallied over 10% from our highlighted entry level.
We continue to see TCL as an attractive opportunity within the infrastructure space.
TCL goes ex-div $0.165 on 29 June.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
Our Algo Model has now closed out one of the best performing investments. After holding Nextdc for 2054 days, the realised gain was 412.93%.
We add IAG to our “high risk” recovery basket, which also includes CIM & A2M.
We expect IAG to see improved earnings into FY22 & FY23. It’s likely we’re nearing the inflection point, where investors begin pricing in the anticipated recovery.
Buy IAG with stops below $4.60
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.